Sten Madsbad

Sten Madsbad

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


Publication year:
All
1 - 10 out of 475Page size: 10
Sort by: 1st author
  1. Published

    Fixed-ratio combination therapy with GLP-1 receptor agonist liraglutide and insulin degludec in people with type 2 diabetes

    Østergaard, L., Frandsen, C. S., Dejgaard, T. F. & Madsbad, Sten, Jun 2017, In: Expert Review of Clinical Pharmacology. 10, 6, p. 621-632 12 p.

    Research output: Contribution to journal › Review › Research › peer-review

  2. Published

    Treatment potential of the GLP-1 receptor agonists in type 2 diabetes mellitus: a review

    Østergaard, L., Frandsen, C. S. & Madsbad, Sten, 2016, In: Expert Review of Clinical Pharmacology. 9, 2, p. 241-65 25 p.

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Effect of weight reductions on estimated kidney function: Post-hoc analysis of two randomized trials

    von Scholten, B. J., Davies, M. J., Persson, F., Hansen, T. W., Madsbad, Sten, Endahl, L., Jepsen, C. H. & Rossing, Peter, 2017, In: Journal of Diabetes and its Complications. 31, 7, p. 1164-1168

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Effect of large weight reductions on measured and estimated kidney function

    von Scholten, B. J., Persson, F., Svane, M. S., Hansen, T. W., Madsbad, Sten & Rossing, Peter, 6 Feb 2017, In: B M C Nephrology. 18, 7 p., 52.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.

    Olsen, Ane Mette Zander, Madsbad, Sten, Madsen, J. L. & Holst, Jens Juul, 2002, In: Lancet. 359, 9309, p. 824-30 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose leves in patients with type 2 diabetes.

    Zander, M., Madsbad, Sten, Deacon, C. & Holst, J., 2006, In: Diabetologia. 49, p. 369-374 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Additive effects of glucagon-like peptide 1 and pioglitazone in patients with type 2 diabetes.

    Olsen, Ane Mette Zander, Christiansen, A., Madsbad, Sten & Holst, Jens Juul, 2004, In: Diabetes Care. 27, 8, p. 1910-4 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes

    Zander, M., Madsbad, Sten, Deacon, Carolyn F. & Holst, Jens Juul, Feb 2006, In: Diabetologia. 49, 2, p. 369-74 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes.

    Zander, M., Taskiran, M., Toft-Nielsen, M. B., Madsbad, Sten & Holst, J. J., 2001, In: Diabetes Care. 24, 4, p. 720-725 6 p.

    Research output: Contribution to journal › Journal article › Research

  10. Published

    Kinetics of insulin and C-peptide and estimation of prehepatic insulin secretion rates after intravenous glucose stimulation using arterial versus venous blood sampling in healthy males

    Wriedt, E. B., Kielgast, U., Svane, M. S., Møller, Søren & Madsbad, Sten, 2024, In: Scandinavian Journal of Clinical and Laboratory Investigation. 84, 1, p. 16-23 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...48 Next

ID: 10877